Видео с ютуба Osimertinib

Osimertinib and chemotherapy as the standard of care in EGFRm NSCLC

Osimertinib for Treatment of EGFR+ Lung Cancer

Osimertinib in Advanced Non–Small-Cell Lung Cancer

Osimertinib poised to change standard of care treatment for patients with locally advanced EGFR-...

Dr. Gold on the Future of Osimertinib in Lung Cancer

20 Medicine of the week: Osimertinib

Dr. Ramalingam on the Use of Osimertinib in Clinical Trial and Real-World Settings

Osimertinib with Chemotherapy in EGFR-Mutated NSCLC | NEJM

Case 4: Metastatic EGFR+ NSCLC Progressing on Osimertinib

Osimertinib in EGFR-Positive NSCLC With Brain Metastases

Case 2: Osimertinib in EGFR-Mutated Lung Cancer

Dr. Oxnard on Detecting Resistance Mechanisms After Treatment With Osimertinib

Safety of osimertinib plus tegavivint in first-line EGFR-mutant NSCLC

Osimertinib + ipilimumab in EGFR-mutated NSCLC

Safety and Efficacy Data for Osimertinib

Dr. Ramalingam on the Role of Osimertinib in eGFR T790M-Positive Advanced NSCLC

Osimertinib for EGFR-mutant lung cancer

Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer

Treating Uncommon EGFR NSCLC Mutations with Osimertinib

Post-osimertinib landscape for NSCLC